Company Valuation: Immunovia AB

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2024 2025 2026 2027 2028
Market Cap 1 1,697 595.2 92.66 152.7 122.4 - -
Change - -64.93% - 64.79% -19.82% - -
Enterprise Value (EV) 1 1,443 526.7 92.66 76.09 55.43 48.43 104.4
Change - -63.5% - -17.88% -27.16% -12.63% 115.64%
P/E -0.11x -0.04x -0.01x -0.54x -1.8x -4.49x -8.98x
PBR 0.04x 0.02x - - - - -
PEG - -0.01x - 0x 0x 0.1x 0.2x
Capitalization / Revenue 1,775x 494x - 203x 38.3x 7.08x 2.23x
EV / Revenue 1,510x 437x - 101x 17.3x 2.8x 1.9x
EV / EBITDA -9.78x -3.17x - -0.97x -0.62x -0.61x -2.22x
EV / EBIT -8.66x -2.76x - -0.95x -0.61x -0.59x -2.09x
EV / FCF -9.27x -2.97x - -0.91x -0.59x -0.56x -1.86x
FCF Yield -10.8% -33.6% - -110% -170% -180% -53.6%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -689 -743 -93 -0.42 -0.1 -0.04 -0.02
Distribution rate - - - - - - -
Net sales 1 0.956 1.204 - 0.752 3.2 17.3 55
EBITDA 1 -147.6 -166.2 - -78.06 -89 -80 -47
EBIT 1 -166.6 -191.2 - -80.38 -91 -82 -50
Net income 1 -156 -168.1 -76.54 -145.9 -91 -82 -50
Net Debt 1 -254.1 -68.47 - -76.6 -67 -74 -18
Reference price 2 75.0000 26.3000 0.5460 0.2270 0.1796 0.1796 0.1796
Nbr of stocks (in thousands) 22,632 22,632 169,711 672,667 672,667 - -
Announcement Date 17/2/22 23/2/23 25/2/25 24/2/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
60.94x4.78x16.03x0.35% 16.4B
42.65x - - 1.9% 1.83B
-10.99x1.32x5.79x-.--% 1.2B
16.43x2.32x7.77x1.43% 984M
53.38x - - 0.84% 547M
53.2x - - - 521M
18.99x2.68x11.46x1.79% 393M
25.52x4.34x14.79x1.85% 372M
Average 32.52x 3.09x 11.17x 1.17% 2.78B
Weighted average by Cap. 51.89x 4.39x 14.86x 0.57%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA